Universidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance

    Journal of Clinical Oncology, Vol. 42, Núm. 27, pp. 3247-3256

  2. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

    Blood cancer journal, Vol. 14, Núm. 1, pp. 74

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

2021

  1. Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study

    Cancer Medicine, Vol. 10, Núm. 21, pp. 7629-7640

2019

  1. Posaconazole salvage therapy: The Posifi study

    Mycoses, Vol. 62, Núm. 6, pp. 526-533

2016

  1. Laboratory parameters provided by Advia 2120 analyser identify structural haemoglobinopathy carriers and discriminate between Hb S trait and Hb C trait

    Journal of Clinical Pathology, Vol. 69, Núm. 10, pp. 912-920

1995

  1. Acquired pure red cell aplasia: a study of six cases

    Annals of Hematology, Vol. 71, Núm. 4, pp. 181-183